Literature DB >> 25049194

Is spinal mobility in patients with spondylitis determined by age, structural damage, and inflammation?

Jerusalem Calvo-Gutierrez1, Juan L Garrido-Castro, Jesus Gil-Cabezas, Cristina Gonzalez-Navas, Pilar Font Ugalde, Loreto Carmona, Eduardo Collantes-Estevez.   

Abstract

OBJECTIVE: To explore the association between mobility, inflammation, and structural damage in ankylosing spondylitis (AS).
METHODS: Patients with AS were included in a cross-sectional study in which spinal mobility was measured by the Bath Ankylosing Spondylitis Metrology Index (BASMI) and by the University of Córdoba Ankylosing Spondylitis Metrology Index (UCOASMI), based on an automated motion analysis. Structural damage was measured by the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS), and activity by the Ankylosing Spondylitis Disease Activity Score (ASDAS) and the Bath Ankylosing Spondylitis Disease Activity (BASDAI). We analyzed the correlations between variables, as well as interaction by multiple linear regression models to reach a predictive equation.
RESULTS: Fifty AS patients, mainly men in their mid-40s and with moderate levels of disease activity and structural damage, were included in the study. BASMI and UCOASMI scores showed a strong correlation (r = 0.89). UCOASMI scores correlated stronger than BASMI with structural damage (r = 0.72 versus r = 0.67) and patient's age (r = 0.68 versus r = 0.56). Correlations of mobility were weaker with disease activity by the ASDAS (r = 0.38) and BASDAI (r = 0.49), and disease duration (r = 0.40). Multiple linear regression showed that factors associated to mobility by UCOASMI were age, the BASDAI, mSASSS, ASDAS (0:<2.1, 1:≥2.1), and disease duration >15 years. The largest weight in the equation corresponded to the mSASSS. The association between the ASDAS and UCOASMI is dependent on disease duration.
CONCLUSION: Mobility in AS is influenced by both structural damage and activity, but definitely also by age and disease duration. Improved mobility should be a relevant target in AS, even more prominently than activity, given its closer relation to structural damage.
Copyright © 2015 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2015        PMID: 25049194     DOI: 10.1002/acr.22400

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  7 in total

Review 1.  Ankylosis in ankylosing spondylitis: current concepts.

Authors:  Nigil Haroon
Journal:  Clin Rheumatol       Date:  2015-06       Impact factor: 2.980

2.  Comparison of MRI-defined back muscles volume between patients with ankylosing spondylitis and control patients with chronic back pain: age and spinopelvic alignment matched study.

Authors:  Doo Hee Bok; Jihye Kim; Tae-Hwan Kim
Journal:  Eur Spine J       Date:  2016-11-24       Impact factor: 3.134

3.  Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage.

Authors:  Clementina López-Medina; Juan L Garrido-Castro; Juan Castro-Jiménez; Cristina González-Navas; Jerusalem Calvo-Gutiérrez; M Carmen Castro-Villegas; Rafaela Ortega-Castro; Alejandro Escudero-Contreras; Pilar Font-Ugalde; Eduardo Collantes-Estévez
Journal:  Clin Rheumatol       Date:  2018-04-24       Impact factor: 2.980

4.  Inter-rater reliability of clinical mobility measures in ankylosing spondylitis.

Authors:  J Calvo-Gutiérrez; J L Garrido-Castro; C González-Navas; M C Castro-Villegas; R Ortega-Castro; C López-Medina; P Font-Ugalde; A Escudero-Contreras; E Collantes-Estévez
Journal:  BMC Musculoskelet Disord       Date:  2016-09-05       Impact factor: 2.362

5.  Measuring Spinal Mobility Using an Inertial Measurement Unit System: A Validation Study in Axial Spondyloarthritis.

Authors:  I Concepción Aranda-Valera; Antonio Cuesta-Vargas; Juan L Garrido-Castro; Philip V Gardiner; Clementina López-Medina; Pedro M Machado; Joan Condell; James Connolly; Jonathan M Williams; Karla Muñoz-Esquivel; Tom O'Dwyer; M Carmen Castro-Villegas; Cristina González-Navas; Eduardo Collantes-Estévez
Journal:  Diagnostics (Basel)       Date:  2020-06-24

6.  Determining factors related to impaired spinal and hip mobility in patients with axial spondyloarthritis: longitudinal results from the DESIR cohort.

Authors:  Pedro D Carvalho; Adeline Ruyssen-Witrand; Joao Fonseca; Ana Marreiros; Pedro M Machado
Journal:  RMD Open       Date:  2020-10

7.  Early achievement of ASDAS clinical response is associated with long-term improvements in metrological outcomes in patients with ankylosing spondylitis treated with TNF-α blockers.

Authors:  Eon Jeong Nam; Won Kee Lee
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.